The provider services M&A market is probably approaching 50% of peak deal volume — well below historical norms — yet J. Kyle Brown sees real momentum building. Kyle is managing director and lead of the provider services group at
Continue Reading The Thaw Has Arrived in Provider Services M&A, With J. Kyle Brown
Healthcare Compliance as a Deal Asset, With Wiks Moffat
Compliance is no longer a fire drill to be ignored. Wiks Moffat, founder and CEO of Calyx Compliance with 30 years of healthcare compliance experience, says the enforcement environment has accelerated, with AI now helping regulators spot outliers.
In
Continue Reading Healthcare Compliance as a Deal Asset, With Wiks MoffatHealthcare & Life Sciences Private Equity Deal Tracker: Arlington Capital Sells Riverpoint Medical to Novanta
Arlington Capital Partners has announced it has agreed to sell Riverpoint Medical to Novanta.
Riverpoint, founded in 2008 and based in Portland, Oregon, designs, develops and markets medical devices for the healthcare and veterinary markets. The company specializes in
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Arlington Capital Sells Riverpoint Medical to NovantaOne Portal for Every Perinatal Journey, With Ian Gardner
Ian Gardner and his wife struggled to assemble a holistic care team during her pregnancy. At the end of their journey, they had a son — and a solution they called MilkWise, a one-stop portal where mothers can access
Continue Reading One Portal for Every Perinatal Journey, With Ian GardnerNavigating Nuances of Life Sciences Post-Closing, With Amy Cassalia
McGuireWoods partner and host Geoff Cockrell invites colleague Amy Cassalia — whose practice is heavily weighted on life sciences transactions — to share insights about the post-closing period of these complex deals. The wide-ranging conversation covers the dynamics of
Continue Reading Navigating Nuances of Life Sciences Post-Closing, With Amy CassaliaAlbaron Partners Closes New Fund With $185 Million
Albaron Partners has announced the close of its flagship fund.
The fund, Albaron Healthcare Opportunities I, closed with $185 million. It was oversubscribed.
Albaron, founded in 2017 and based in New York, is a lower middle market private equity
Continue Reading Albaron Partners Closes New Fund With $185 MillionGP-Led Secondaries in Lower Middle Market, With Chris Lawrence
The secondary market has grown to roughly $220 billion as GPs and LPs scramble for liquidity in a private markets cycle stuck in a “worse distribution profile” for three and a half years. Chris Lawrence, managing partner at
Continue Reading GP-Led Secondaries in Lower Middle Market, With Chris LawrenceHealthcare & Life Sciences Private Equity Deal Tracker: Eir Partners Acquires QuartzBio
Eir Partners has acquired a controlling interest in QuartzBio, according to a news release.
QuartzBio, founded in 2012 and based in Frederick, Maryland, is a life science technology company that provides connected sample and biomarker intelligence for clinical-stage
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Eir Partners Acquires QuartzBioOncology and Retina: Follow the Drug Spend, With Jeanne Proia
Oncology commands roughly 40% of the national drug spend. Retina is close behind. “If you follow the drug spend, you’ll find that the distributors are really building an ecosystem around it,” says Jeanne Proia, managing director at Cross
Continue Reading Oncology and Retina: Follow the Drug Spend, With Jeanne ProiaBuilding a Gastroenterology Program That’s ‘Second to None,’ With Matt Devine
How did Allied Digestive Health build a gastroenterology program that’s “second to none” with roughly 200 gastroenterologists across New York and New Jersey? CEO Matt Devine unpacks the strategies, such as investing in technology and having one EMR across
Continue Reading Building a Gastroenterology Program That’s ‘Second to None,’ With Matt Devine